Active substance
Results for the substance covid-19 vaccine (recombinant, with adjuvant)
1 result
About this active substance
The COVID-19 vaccine (recombinant, adjuvanted) is used to prevent infection with the SARS-CoV-2 virus, responsible for the COVID-19 pandemic. This type of vaccine uses recombinant technology to produce the virus's spike protein, which is combined with an adjuvant to stimulate a stronger and more durable immune response.
The vaccine is administered intramuscularly, usually in two doses, a few weeks apart, according to the manufacturer's recommendations. It is intended for adults and adolescents, and its efficacy has been demonstrated in preventing severe forms of COVID-19 and hospitalizations.
Common side effects include pain at the injection site, fever, fatigue, muscle aches, and headache. In very rare cases, severe allergic reactions or other adverse effects may occur.
The COVID-19 vaccine (recombinant, adjuvanted) is an essential measure in combating the pandemic, helping to reduce virus transmission and protect public health.
The vaccine is administered intramuscularly, usually in two doses, a few weeks apart, according to the manufacturer's recommendations. It is intended for adults and adolescents, and its efficacy has been demonstrated in preventing severe forms of COVID-19 and hospitalizations.
Common side effects include pain at the injection site, fever, fatigue, muscle aches, and headache. In very rare cases, severe allergic reactions or other adverse effects may occur.
The COVID-19 vaccine (recombinant, adjuvanted) is an essential measure in combating the pandemic, helping to reduce virus transmission and protect public health.